Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialRobin K. Avery, Roy F. Chemaly, Catherine Cordonnier et al.|Clinical Infectious Diseases|2021Cited by 299
A Direct and Indirect Comparison Meta-Analysis on the Efficacy of Cytomegalovirus Preventive Strategies in Solid Organ TransplantDiana F. Florescu, André C. Kalil|Clinical Infectious Diseases|2014Cited by 87
920. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant RecipientsC Boutin, Michelle Callegari, Diana F. Florescu et al.|American Journal of Transplantation|2023Cited by 2